CSTB

Chr 21AR

cystatin B

Also known as: CPI-B, CST6, EPM1, EPM1A, PME, STFB, ULD

The cystatin superfamily encompasses proteins that contain multiple cystatin-like sequences. Some of the members are active cysteine protease inhibitors, while others have lost or perhaps never acquired this inhibitory activity. There are three inhibitory families in the superfamily, including the type 1 cystatins (stefins), type 2 cystatins and kininogens. This gene encodes a stefin that functions as an intracellular thiol protease inhibitor. The protein is able to form a dimer stabilized by noncovalent forces, inhibiting papain and cathepsins l, h and b. The protein is thought to play a role in protecting against the proteases leaking from lysosomes. Evidence indicates that mutations in this gene are responsible for the primary defects in patients with progressive myoclonic epilepsy (EPM1). One type of mutation responsible for EPM1 is the expansion in the promoter region of this gene of a CCCCGCCCCGCG repeat from 2-3 copies to 30-78 copies. [provided by RefSeq, Jul 2016]

Primary Disease Associations & Inheritance

Epilepsy, progressive myoclonic 1A (Unverricht and Lundborg)MIM #254800
AR
290
ClinVar variants
112
Pathogenic / LP
0.01
pLI score
0
Active trials
Clinical SummaryCSTB
🧬
Gene-Disease Validity (ClinGen)
Unverricht-Lundborg syndrome · ARDefinitive

Definitive — sufficient evidence for diagnostic panels

2 total gene-disease associations curated

Population Constraint (gnomAD)
Low constraint (pLI 0.01) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
112 Pathogenic / Likely Pathogenic· 90 VUS of 290 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?LOEUF (Loss-of-function Observed/Expected Upper bound Fraction) is the upper bound of the 90% CI for LoF OE — the preferred gnomAD v4 metric. Lower = more intolerant to LoF. LOEUF < 0.35 = highly constrained.
1.85LOEUF
pLI 0.007
Z-score 0.01
OE 0.99 (0.431.85)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint?Missense Z-score: standard deviations fewer missense variants observed vs. expected. Z > 3.09 (p < 0.001) = gene does not tolerate missense variation. OE missense < 0.6 is also considered constrained.
0.02Z-score
OE missense 0.99 (0.791.25)
52 obs / 52.3 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?Shaded band = 90% confidence interval. Vertical tick = point estimate. Grey threshold line = gnomAD constraint cutoff for that variant class.
LoF OE?Ratio of observed to expected LoF variants. Upper CI bound (LOEUF) ≤ 0.35 = strong LoF constraint signal.0.99 (0.431.85)
00.351.4
Missense OE?Ratio of observed to expected missense variants. OE ≤ 0.6 = fewer missense variants than expected by chance.0.99 (0.791.25)
00.61.4
Synonymous OE?Control metric — synonymous variants are largely neutral and expected near OE = 1.0. Significant deviation may indicate annotation issues.0.85
01.21.6
LoF obs/exp: 3 / 3.0Missense obs/exp: 52 / 52.3Syn Z: 0.58

ClinVar Variant Classifications

290 submitted variants in ClinVar

Classification Summary

Pathogenic96
Likely Pathogenic16
VUS90
Likely Benign67
Benign8
Conflicting13
96
Pathogenic
16
Likely Pathogenic
90
VUS
67
Likely Benign
8
Benign
13
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
5
2
89
0
96
Likely Pathogenic
4
1
9
2
16
VUS
1
52
36
1
90
Likely Benign
0
0
38
29
67
Benign
0
0
8
0
8
Conflicting
13
Total105518032290

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

CSTB · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Gene2Phenotype Curations

CSTB-related Unverricht-Lundborg disease

definitive
ARLoss Of FunctionAbsent Gene Product
Dev. Disorders
G2P ↗

Gene2Phenotype curations · DECIPHER consortium patient cohort (public variants) · deciphergenomics.org

OMIM — Genotype-Phenotype Relationships

1 OMIM entry

CYSTATIN B; CSTB
MIM #601145 · *

Epilepsy, progressive myoclonic 1A (Unverricht and Lundborg)

MIM #254800

Molecular basis of disorder known

Autosomal recessive
📖
GeneReview available — CSTB
Authoritative clinical overview · NCBI Bookshelf · Recommended first read
Open GeneReview ↗
Clinical Literature
Landmark / reviewRecent case evidence
Key Publications
Landmark & review papers · by relevance
PubMed
Unverricht-Lundborg disease.
Crespel A et al.·Epileptic Disord
2016Review
[Consensus on linezolid in the treatment of tuberculosis(2022 update)].
Chinese Society for Tuberculosis et al.·Zhonghua Jie He He Hu Xi Za Zhi
2022
Top 10 resultsSearch PubMed ↗

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →